155 related articles for article (PubMed ID: 35563215)
1. Implications of Heparanase on Heparin Synthesis and Metabolism in Mast Cells.
Maccarana M; Jia J; Li H; Zhang X; Vlodavsky I; Li JP
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563215
[TBL] [Abstract][Full Text] [Related]
2. Processing of macromolecular heparin by heparanase.
Gong F; Jemth P; Escobar Galvis ML; Vlodavsky I; Horner A; Lindahl U; Li JP
J Biol Chem; 2003 Sep; 278(37):35152-8. PubMed ID: 12837765
[TBL] [Abstract][Full Text] [Related]
3. Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin.
Wang B; Jia J; Zhang X; Zcharia E; Vlodavsky I; Pejler G; Li JP
J Allergy Clin Immunol; 2011 Dec; 128(6):1310-1317.e8. PubMed ID: 21575986
[TBL] [Abstract][Full Text] [Related]
4. Heparanase-mediated cleavage of macromolecular heparin accelerates release of granular components of mast cells from extracellular matrices.
Higashi N; Waki M; Sue M; Kogane Y; Shida H; Tsunekawa N; Hasan A; Sato T; Kitahara A; Kasaoka T; Hayakawa Y; Nakajima M; Irimura T
Biochem J; 2014 Mar; 458(2):291-9. PubMed ID: 24344642
[TBL] [Abstract][Full Text] [Related]
5. Incorporation, intracellular trafficking and processing of extracellular heparanase by mast cells: Involvement of syndecan-4-dependent pathway.
Higashi N; Waki M; Sudo Y; Suzuki S; Oku T; Tsuiji M; Tsuji T; Miyagishi M; Takahashi K; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2018 Sep; 503(4):3235-3241. PubMed ID: 30149916
[TBL] [Abstract][Full Text] [Related]
6. Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin.
Nasser NJ; Sarig G; Brenner B; Nevo E; Goldshmidt O; Zcharia E; Li JP; Vlodavsky I
J Thromb Haemost; 2006 Mar; 4(3):560-5. PubMed ID: 16460439
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional characterization of glycosaminoglycans released from degranulating rat peritoneal mast cells: Insights into the physiological role of endogenous heparin.
Lever R; Smailbegovic A; Riffo-Vasquez Y; Gray E; Hogwood J; Francis SM; Richardson NV; Page CP; Mulloy B
Pulm Pharmacol Ther; 2016 Dec; 41():96-102. PubMed ID: 27816772
[TBL] [Abstract][Full Text] [Related]
8. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
Bashkin P; Razin E; Eldor A; Vlodavsky I
Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I
Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820
[TBL] [Abstract][Full Text] [Related]
10. Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.
Bohdan N; Espín S; Águila S; Teruel-Montoya R; Vicente V; Corral J; Martínez-Martínez I
PLoS One; 2016; 11(6):e0157834. PubMed ID: 27322195
[TBL] [Abstract][Full Text] [Related]
11. Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin.
Horner AA
Biochem J; 1986 Nov; 240(1):171-9. PubMed ID: 3827837
[TBL] [Abstract][Full Text] [Related]
12. Anti-heparanase activity of ultra-low-molecular-weight heparin produced by physicochemical depolymerization.
Achour O; Poupard N; Bridiau N; Bordenave Juchereau S; Sannier F; Piot JM; Fruitier Arnaudin I; Maugard T
Carbohydr Polym; 2016 Jan; 135():316-23. PubMed ID: 26453883
[TBL] [Abstract][Full Text] [Related]
13. Heparanase - Discovery and Targets.
Lindahl U; Li JP
Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
[TBL] [Abstract][Full Text] [Related]
14. Non-Anticoagulant Heparins as Heparanase Inhibitors.
Cassinelli G; Torri G; Naggi A
Adv Exp Med Biol; 2020; 1221():493-522. PubMed ID: 32274724
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
16. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
18. Effects of aging on the synthesis of antithrombin-binding sites on heparin chains and heparan sulphate chains in the rat.
Horner AA
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):245-9. PubMed ID: 7492320
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold.
Craig SS; Irani AM; Metcalfe DD; Schwartz LB
Lab Invest; 1993 Nov; 69(5):552-61. PubMed ID: 8246447
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.
Zcharia E; Metzger S; Chajek-Shaul T; Aingorn H; Elkin M; Friedmann Y; Weinstein T; Li JP; Lindahl U; Vlodavsky I
FASEB J; 2004 Feb; 18(2):252-63. PubMed ID: 14769819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
